Gadolinium Lawsuit |
|
Lawyers Represent People Harmed by Gadolinium-Based Contrast Agents |
|
FDA Orders Black Box Warning on Gadolinium Agents |
|
 |
May 23, 2007—The FDA announced that it is asking manufacturers of gadolinium-based contrast agents to include a black box warning alterting patients to the risk of a potentially fatal disease. The FDA stated that patients with kidney disease or chronic liver disease are at risk for developing nephrogenic systemic fibrosis, a disease characterized by a thickening of the skin and connective tissues that inhibit their ability to move. The following gadolinium-based agents are implicated by the warning:
The FDA has been aware of problems with gadolinium since at least June 2006, when the agency warned healthcare professionals about the risk of nephrogenic systemic fibrosis. A subsequent warning was issued in December 2006. The FDA stated it has received 128 reports of nephrogenic systemic fibrosis in patients who used gadolinium-based agents. |
About Gadolinium |
|
|
Gadolinium is a metal ion used with patients undergoing magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). Gadolinium-based agents are approved by the FDA as contrast agents to provide a clearer picture of organs and tissues. |
What You Should Do |
|
 |
Your Health |
| If you or a loved one has been given a gadolinium-based agent and you are concerned about your health, promptly consult your physician for an evaluation. | |
Your Legal Rights |
|
If you have been diagnosed with nephrogenic systemic fibrosis, you may be entitled to compensation. You should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals. |
|
Our Lawyers Can Help |
|
 |
O'Steen & Harrison, PLC presently is investigating legal claims on behalf of those diagnosed with nephrogenic systemic fibrosis as a result of gadolinium-based agents. We invite you to contact us for a free, confidential consultation about your legal rights. We will represent patients throughout the United States. We can help you, too, wherever you live. For free answers to your questions about gadolinium, please call us toll-free at 1-800-883-8888 or complete this online contact form. |
O'Steen & Harrison, PLC |
300 W. Clarendon Ave., Suite 400 800.883.8888 |
Current Consumer Cases |
Contact Us |
Why You Should Choose Us |
We have represented thousands of people, including some of the largest and most important injury cases ever brought in the United States. In the single largest damages case in the history of the world, our attorneys were selected by the Arizona Attorney General as the only Arizona law firm to represent the State against American tobacco companies. As a result, Arizona taxpayers will receive more than three billion dollars to cover the costs of treating tobacco-related illnesses, maintain educational programs to prevent young people from smoking, and fund other important State programs. |
Gadolinium News |
FDA Orders Warnings on MRI Contrast Agents FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI Imaging FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents |